DE69533673D1 - Behandlung und prävention von helicobacter-infektionen - Google Patents
Behandlung und prävention von helicobacter-infektionenInfo
- Publication number
- DE69533673D1 DE69533673D1 DE69533673T DE69533673T DE69533673D1 DE 69533673 D1 DE69533673 D1 DE 69533673D1 DE 69533673 T DE69533673 T DE 69533673T DE 69533673 T DE69533673 T DE 69533673T DE 69533673 D1 DE69533673 D1 DE 69533673D1
- Authority
- DE
- Germany
- Prior art keywords
- prevention
- treatment
- helicobacter infections
- helicobacter
- catalase enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000028861 Helicobacter pylori infectious disease Diseases 0.000 title 1
- 102000016938 Catalase Human genes 0.000 abstract 2
- 108010053835 Catalase Proteins 0.000 abstract 2
- 241000589989 Helicobacter Species 0.000 abstract 1
- 241000590017 Helicobacter felis Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM6124A AUPM612494A0 (en) | 1994-06-08 | 1994-06-08 | Treatment or prevention of helicobacter infection |
AUPM612494 | 1994-06-08 | ||
PCT/AU1995/000335 WO1995033482A1 (en) | 1994-06-08 | 1995-06-08 | Treatment and prevention of helicobacter infection |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69533673D1 true DE69533673D1 (de) | 2004-11-25 |
DE69533673T2 DE69533673T2 (de) | 2006-03-09 |
Family
ID=3780694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69533673T Expired - Fee Related DE69533673T2 (de) | 1994-06-08 | 1995-06-08 | Behandlung und prävention von helicobacter-infektionen |
Country Status (9)
Country | Link |
---|---|
US (3) | US6005090A (de) |
EP (1) | EP0771214B1 (de) |
JP (1) | JPH10500958A (de) |
KR (1) | KR100368475B1 (de) |
AT (1) | ATE279940T1 (de) |
AU (1) | AUPM612494A0 (de) |
DE (1) | DE69533673T2 (de) |
NZ (1) | NZ287385A (de) |
WO (1) | WO1995033482A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
AUPM399594A0 (en) * | 1994-02-21 | 1994-03-17 | Csl Limited | Antigenic preparation for treatment or prevention of helicobacter infection |
AUPM612494A0 (en) | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
AU695769B2 (en) * | 1994-07-01 | 1998-08-20 | Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The | Helicobacter proteins and vaccines |
DE69636320T2 (de) * | 1995-06-02 | 2007-07-26 | Eisai R&D Management Co., Ltd. | Helicobacter Polypeptide, deren Herstellung und Verwendung |
WO1997025429A1 (en) * | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
US6551779B1 (en) | 1996-05-31 | 2003-04-22 | Tosiro Sugiyama | Helicobactor catalase nucleotide sequences, their production and use |
US5939300A (en) * | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
JP3430853B2 (ja) | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
JP2002512619A (ja) * | 1997-04-30 | 2002-04-23 | メリウクス オラバクス | 横隔膜下からの全身経路に使用するための抗ヘリコバクターワクチン組成物、および粘膜/非経口複合免疫法 |
US6599509B2 (en) * | 1997-09-02 | 2003-07-29 | Massachusetts Institute Of Technology | Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
US20020151462A1 (en) * | 1998-02-19 | 2002-10-17 | Ling Lissolo | Helicobacter pylori membrane proteins |
US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
CA2335487A1 (en) * | 1998-06-19 | 1999-12-23 | Merieux Oravax | Lt and ct in parenteral immunization methods against helicobacter infection |
DK1232392T3 (da) * | 1999-10-12 | 2003-07-28 | Connex Ges Zur Optimierung Von | Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring |
AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
AU772513B2 (en) * | 1999-10-15 | 2004-04-29 | Csl Limited | Polypeptide fragments comprising C-terminal portion of helicobacter catalase |
DE60045870D1 (de) * | 1999-10-29 | 2011-06-01 | Wakamoto Pharma Co Ltd | Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit |
AU2001279803A1 (en) * | 2000-07-05 | 2002-01-30 | Merieux Oravax | Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
CA2458854A1 (en) * | 2001-08-31 | 2003-03-06 | Chiron Srl | Helicobacter pylori vaccination |
CA2733836A1 (en) * | 2011-03-09 | 2012-09-09 | Coorga International Holding Ltd. | Oral dietary supplementation for addressing of human canities |
CA2831535C (en) * | 2011-04-07 | 2014-10-21 | Histapharm Inc. | Oral enzyme compositions for intestinal delivery |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
US5234910A (en) * | 1989-07-18 | 1993-08-10 | University Hospital | Acid inhibitor of bacterial origin |
US5258178A (en) * | 1990-07-30 | 1993-11-02 | Abbott Laboratories | Method and product for the treatment of gastric disease |
WO1992015689A1 (en) * | 1991-03-05 | 1992-09-17 | The Wellcome Foundation Limited | Expression of recombinant proteins in attenuated bacteria |
US5262156A (en) * | 1991-08-12 | 1993-11-16 | Hycor Biomedical, Inc. | Antigenic compositions and their use for the detection of Helicobacter pylori |
JP3920320B2 (ja) * | 1992-02-26 | 2007-05-30 | ヴァンダービルト ユニバーシティ | 精製されたHelicobacter pylori由来の空胞形成毒素およびその使用方法 |
MX9301706A (es) * | 1992-04-13 | 1994-05-31 | Oravax Inc | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. |
US5420014A (en) * | 1992-04-30 | 1995-05-30 | Auspharm International Ltd. | Rapid in vitro test for helicobacter pylori using saliva |
AU4924893A (en) * | 1992-09-16 | 1994-04-12 | Galagen, Inc. | Antibody treatment of (helicobacter pylori) |
US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
NZ314585A (en) * | 1993-07-27 | 2000-08-25 | Univ New South Wales | Method of treating H. Pylori associated gastroduodenal disease |
US6191268B1 (en) * | 1993-12-17 | 2001-02-20 | Dana-Farber Cancer Institute | Compositions and methods relating to DNA mismatch repair genes |
FR2719998B1 (fr) * | 1994-04-08 | 1996-09-27 | Pasteur Merieux Serums Vacc | Composition immunisante anti-hélicobacter pylori à base de catalase. |
AUPM612494A0 (en) * | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
US5498528A (en) * | 1994-06-10 | 1996-03-12 | King; Wing | Detection of helicobacter pylori |
US5610060A (en) * | 1994-06-24 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Isolated Helicobacter hepaticus |
US5837240A (en) * | 1995-04-28 | 1998-11-17 | Oravax-Merieux Co. | Multimeric, recombinant urease vaccine |
AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
DE69636320T2 (de) * | 1995-06-02 | 2007-07-26 | Eisai R&D Management Co., Ltd. | Helicobacter Polypeptide, deren Herstellung und Verwendung |
US5939300A (en) * | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
-
1994
- 1994-06-08 AU AUPM6124A patent/AUPM612494A0/en not_active Abandoned
-
1995
- 1995-06-08 EP EP95920717A patent/EP0771214B1/de not_active Expired - Lifetime
- 1995-06-08 DE DE69533673T patent/DE69533673T2/de not_active Expired - Fee Related
- 1995-06-08 WO PCT/AU1995/000335 patent/WO1995033482A1/en active IP Right Grant
- 1995-06-08 NZ NZ287385A patent/NZ287385A/xx not_active IP Right Cessation
- 1995-06-08 KR KR1019960706972A patent/KR100368475B1/ko not_active IP Right Cessation
- 1995-06-08 AT AT95920717T patent/ATE279940T1/de not_active IP Right Cessation
- 1995-06-08 JP JP8500091A patent/JPH10500958A/ja active Pending
-
1996
- 1996-08-15 US US08/695,987 patent/US6005090A/en not_active Expired - Fee Related
-
1998
- 1998-01-07 US US09/004,014 patent/US6630582B1/en not_active Expired - Fee Related
-
1999
- 1999-10-20 US US09/421,238 patent/US6468545B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1995033482A1 (en) | 1995-12-14 |
KR970703164A (ko) | 1997-07-03 |
ATE279940T1 (de) | 2004-11-15 |
EP0771214A1 (de) | 1997-05-07 |
US6468545B1 (en) | 2002-10-22 |
JPH10500958A (ja) | 1998-01-27 |
KR100368475B1 (ko) | 2003-04-11 |
AUPM612494A0 (en) | 1994-06-30 |
EP0771214B1 (de) | 2004-10-20 |
US6005090A (en) | 1999-12-21 |
EP0771214A4 (de) | 1998-07-29 |
NZ287385A (en) | 1998-10-28 |
US6630582B1 (en) | 2003-10-07 |
DE69533673T2 (de) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE279940T1 (de) | Behandlung und prävention von helicobacter- infektionen | |
ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
AU7144901A (en) | Human papilloma virus treatment | |
NO963508L (no) | Urease-basert vaksine og behandling av Helicobacter-infeksjon | |
EP0915648A4 (de) | ||
HU901585D0 (en) | Method for treatment of viral infections using functional derivatives of icam-1 | |
ATE222930T1 (de) | Antigene arznei zur behandlung oder vorbeugung | |
HK1005541A1 (en) | Treatment of helicobacter associated gastroduodenal disease | |
HU9700023D0 (en) | Pyridyl-thio-compounds, their application again helicobacter bacterium | |
ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
WO2001040473A3 (en) | Pseudomonas aeruginosa antigens | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
LU90378I2 (fr) | Tetravac | |
HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
ATE108335T1 (de) | Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. | |
AU673344B2 (en) | Vaccines based on streptokinase | |
NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
DE69116155T2 (de) | Neuramidase und glulaktoseoxidase als vaccinadjuvans | |
CA2191440A1 (en) | Treatment and prevention of helicobacter infection | |
NZ331674A (en) | Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection | |
UA36485A (uk) | Спосіб лікування генералізованого пародонтиту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |